Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,225 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07292909RecruitingPhase 4
Effect of Empagliflozin on Inflammation for Coronary Patients
This trial tests if the diabetes drug empagliflozin can help reduce inflammation in people with stable coronary artery disease who are planning to have a stent placed. It may offer a new way to protect heart health.
Beirut, BeirutAges 18 years+ - NCT07293260RecruitingPhase 3
Olpasiran heart scan study for high Lp(a) patients
This study tests if a medication called olpasiran can lower a type of fat in your blood called Lp(a), which is linked to heart problems. You take the medicine or a placebo and get a special heart scan to see changes in your arteries.
Bridgeport, ConnecticutAges 35–80 - NCT07294235RecruitingPhase 1
Study of BGM1812 injection for healthy and overweight or obese participants
This trial tests an investigational drug called BGM1812 given as an injection. It is for healthy Chinese adults who are either at a normal weight or are overweight/obese but not diabetic. The study will see how the drug works in the body and check for side effects.
Kunming, YunnanAges 18–55 - NCT07295509RecruitingPhase 2/Phase 3
Testing picankibart for active psoriatic arthritis
This trial tests a new drug called picankibart to see if it helps people with active psoriatic arthritis who haven't gotten enough relief from standard treatments like NSAIDs or non-biologic DMARDs. It may be an option if you have at least 3 tender and 3 swollen joints and active or past plaque psoriasis.
Hangzhou, ZhejiangAges 18–75 - NCT07295717RecruitingPhase 1
ALN-4285 safety study in healthy adults
This study tests a new medicine called ALN-4285 in healthy adults to see how safe it is and how the body processes it. It may help find a new treatment for certain conditions.
LondonAges 18–65 - NCT07296484RecruitingPhase 2
Clofutriben for hard-to-control type 2 diabetes
This trial tests a new medication, clofutriben, for people with hard-to-control type 2 diabetes who might also have mild excess of a stress hormone called cortisol. It aims to see if the drug can help lower blood sugar and improve diabetes management.
Chandler, ArizonaAges 18 years+ - NCT07297290RecruitingPhase 3
Testing Metformin for Weight Loss in Obesity
This trial tests whether metformin, a common diabetes medicine, can help people with obesity lose weight. It is for people who do not have diabetes and have not used weight loss treatments in the past year.
Enugu, Enugu StateAges 20–59 - NCT07297966RecruitingPhase 2
Probiotics for recurrent respiratory infections in children
This trial tests if a daily probiotic can help young children who get frequent respiratory infections like colds and coughs. It aims to see if the probiotic reduces how often infections happen.
Xingyi, GuangdongAges 1 day–6 years - NCT07298343RecruitingPhase 2
Testing ZED1227 for non-responsive celiac disease
This trial tests a new medicine, ZED1227, for people with celiac disease who still have symptoms despite eating gluten-free. The goal is to see if it helps reduce those symptoms.
MainzAges 18–80 - NCT07298408RecruitingPhase 1/Phase 2
CBD for Diabetic Nerve Pain: A Pilot Study
This trial tests whether a daily dose of CBD (a cannabis compound) can help reduce nerve pain from type 2 diabetes. It's a small, early study to see if it's safe and effective.
Tallahassee, FloridaAges 40–70 - NCT07298811RecruitingPhase 1/Phase 2
Healthy eye bacteria for dry eye treatment
This study tests whether putting healthy bacteria from a family member's eye surface onto your eyes can help treat moderate to severe dry eye. You would receive standard dry eye drops plus the experimental transplant.
Nanchang, JiangxiAges 18–70 - NCT07298824RecruitingPhase 2
Study of MR-61 to slow nearsightedness in children and teens
This trial tests if MR-61 can help slow down the progression of myopia (nearsightedness) in children and teenagers. It may be an option for patients between 3 and 18 years old who are already nearsighted and have no other eye problems.
Nanchang, JiangxiAges 3–18 - NCT07299422RecruitingPhase 2
Study of SHR-2173 for people with lupus
This trial tests a new drug called SHR-2173 for people with active lupus. It aims to see if it can reduce disease activity when taken with standard treatments.
Beijing, Beijing MunicipalityAges 18–65 - NCT07299474Recruiting
Lavender scent for anxiety and pain during awake ENT procedures
This study tests whether smelling lavender essential oil during an awake ear, nose, or throat procedure can help reduce anxiety and pain. If you qualify, you may receive the lavender scent during your procedure and report how you feel.
Los Angeles, CaliforniaAges 18 years+ - NCT07299851Recruiting
Fatty acid supplement for bone healing after a leg fracture
This trial tests whether a supplement made from cetylated fatty acids can help heal a simple leg bone fracture faster after surgery. You might be eligible if you have a specific type of leg fracture fixed with a metal rod inside the bone.
Deurne, AntwerpAges 18–85 - NCT07299942Recruiting
Beta-glucan supplement for weight loss in women
This trial tests whether taking a beta-glucan supplement (a type of fiber) during a calorie- and carb-restricted diet helps with losing body weight and fat, controlling appetite, and managing hunger hormones. It is for healthy women who are overweight or obese and not following a special diet.
GlasgowAges 18–60 - NCT07301203RecruitingPhase 1
Healthy volunteer study of inhaled CPD704
This early-phase study tests a new inhaled medication called CPD704 in healthy volunteers. It checks safety and how the body processes the drug.
Beijing, Beijing MunicipalityAges 18–55 - NCT07301320RecruitingPhase 2
Epetraborole for Mycobacterium abscessus lung infection
This study tests an investigational medication called epetraborole for people with a chronic lung infection caused by Mycobacterium abscessus bacteria. You may be able to join if your infection is stable enough to delay standard treatment and you have symptoms like cough, fatigue, or weight loss.
Portland, OregonAges 18 years+ - NCT07301333RecruitingPhase 1
Study of HRS-6257 in healthy volunteers
This study tests a new investigational drug called HRS-6257 in healthy volunteers. It looks at how the drug works in the body and checks for side effects after one or several doses.
Changsha, HunanAges 18–55 - NCT07303595Recruiting
Postnatal multivitamin supplement trial for new moms
This trial tests a multivitamin supplement designed for new mothers. It looks at how the supplement affects your health in the weeks after giving birth. If you are about 4 weeks postpartum and had a healthy pregnancy, this study might be for you.
Athens, GeorgiaAges 18 years+ - NCT07303803RecruitingPhase 2
Testing Chiglitazar for fatty liver with diabetes
This trial tests a new oral medication, Chiglitazar, for people who have both type 2 diabetes and a fatty liver condition called MASH (fatty liver with inflammation and scarring). It aims to see if the drug can help improve liver health and diabetes control.
Beijing, Beijing MunicipalityAges 18–75 - NCT07303816RecruitingPhase 4
Can statins prevent blood clots in cancer patients?
This trial tests whether a daily statin (rosuvastatin) can help prevent dangerous blood clots in people with advanced cancer who are starting new cancer therapy. It is for those at medium or high risk for clots, based on a simple risk score.
Boston, MassachusettsAges 18 years+ - NCT07303894RecruitingPhase 2
Isoquercetin for ovarian cancer patients
This trial tests if a plant-based supplement called isoquercetin can help people with ovarian cancer when given alongside their first chemotherapy. It aims to see if it improves treatment results.
Boston, MassachusettsAges 18 years+ - NCT07304089RecruitingPhase 2
Study of VIM0423 for people with dystonia
This trial tests an experimental drug called VIM0423 for people with isolated dystonia (a condition causing muscle spasms in multiple body parts). It aims to see if the drug can improve symptoms safely.
Birmingham, AlabamaAges 18–65
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,225 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.